These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13415121)

  • 21. Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups.
    Cherry JD; Mortimer EA; Hackell JG; Scott JV
    Dev Biol Stand; 1991; 73():51-8. PubMed ID: 1778334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus.
    Martins-Green M; Boudreau N; Bissell MJ
    Cancer Res; 1994 Aug; 54(16):4334-41. PubMed ID: 7519120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C; Linder S; Munck-Wikland E; Strander H
    Anticancer Res; 1998; 18(3B):2063-8. PubMed ID: 9677468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on anti-tumor activity of soedomycin, a new anti-tumor agent. II. Anti-tumor effect on Ehrlich ascites tumor and Yoshida sarcoma, and an outline of clinical application to human patients with carcinoma.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1492-501. PubMed ID: 5231928
    [No Abstract]   [Full Text] [Related]  

  • 25. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
    Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
    Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
    Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
    J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does varied parenteral zinc administration modify interaction between tumor and host? Studies based on an animal model].
    Wolters U; Müller JM; Wölfelschneider K; Iffland H
    Infusionstherapie; 1991 Jun; 18(3):123-8. PubMed ID: 1917053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma.
    Fraker DL; Alexander HR
    Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489
    [No Abstract]   [Full Text] [Related]  

  • 29. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.
    Ladanyi M; Gerald W
    Cancer Res; 1994 Jun; 54(11):2837-40. PubMed ID: 8187063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of therapeutic targets in Ewing sarcoma family tumors.
    Ahmed AA; Sherman AK; Pawel BR
    Hum Pathol; 2012 Jul; 43(7):1077-83. PubMed ID: 22196127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Another case of multiple malignant tumor].
    NOVAK R
    Acta Chir Iugosl; 1954; 1(1-2):146-51. PubMed ID: 13180131
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
    Keppler BK; Diez A; Seifried V
    Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
    Chung CH; Chiang J; Jiang CM; Chen YY; Huang CY; Chen PG; Chen YJ
    Neoplasma; 2001; 48(3):192-9. PubMed ID: 11583288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J; Mrácek J; Havlas V; Trc T
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting angiogenesis for the treatment of sarcoma.
    Balasubramanian L; Evens AM
    Curr Opin Oncol; 2006 Jul; 18(4):354-9. PubMed ID: 16721130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.